SPARK ORTHODONTICS v. ORMCO CORPORATION

CourtDistrict Court, E.D. Pennsylvania
DecidedMarch 2, 2022
Docket5:21-cv-02841
StatusUnknown

This text of SPARK ORTHODONTICS v. ORMCO CORPORATION (SPARK ORTHODONTICS v. ORMCO CORPORATION) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
SPARK ORTHODONTICS v. ORMCO CORPORATION, (E.D. Pa. 2022).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA

SPARK DSO, LLC, as Assignee of SPARK ORTHODONTICS, PLLC, f/k/a SPARK ORTHODONTICS, P.C. : CIVIL ACTION : v. : NO. 21-2841 : ORMCO CORPORATION :

MEMORANDUM

SCHMEHL, J. /s/ JLS MARCH 2, 2022

INTRODUCTION Plaintiff brought this action, claiming that Defendant Ormco Corporation’s (“Ormco”) use of the mark “SPARK” in connection with the manufacture, marketing and sale of its orthodontic teeth aligners (“Spark Clear Aligner System”) infringes on Plaintiff’s federally-registered trademark “SPARK ORTHODONTICS.” Plaintiff has asserted claims under Section 32(1) of the Lanham Act, 15 U.S.C. § 1114(1), unfair competition and false designation of origin under Section 43(a) of the Lanham Act, 15 U.S.C. § 1125(a), and for trademark infringement and unfair or deceptive acts or practices under the common laws of the Commonwealth of Pennsylvania (54 Pa.Cons.Stat.Ann. § 1126 and 73 Pa.Cons.Stat. § 201-2(4)). Presently before the Court is the motion of the Plaintiff for a preliminary injunction. For the reasons that follow, the motion is denied. PROCEDURAL HISTORY On June 24, 2014, the United States Patent and Trademark Office (“USPTO”) registered for Spark Orthodontics, PLLC, f/k/a Spark Orthodontics, P.C. the trademark “Spark Orthodontics” for use in connection with orthodontic services.1 Am. Compl. at ¶ 10; [ECF 10-4, Ex. 1]. At the current time, Plaintiff’s use of its mark is limited to its locations within the Commonwealth of Pennsylvania. On January 18, 2018, Ormco filed an application with the USPTO to register the

trademark “Spark” for use in connection with teeth aligners. Id. at ¶15; [ECF 10-4, Ex. 3]. On April 30, 2018, the USPTO issued an Office Action which refused registration of Ormco’s “Spark” mark under 15 U.S.C.§ 1052(d) based on a likelihood of confusion with Plaintiff’s trademark of “Spark Orthodontics.” Id. at ¶16. On October 24, 2018, Ormco filed a response to the Office Action in which it argued that “…the products and services are offered to different classes of consumers” and, “…the goods and services are rendered to different classes of consumers. Applicant’s goods will be sold solely to orthodontist’s and dentist’s offices. Whereas the Cited Mark’s services are marketed and sold to general consumers seeking orthodontic

services.” Id. at ¶17. On November 15, 2018, the USPTO examining attorney rejected Ormco’s arguments and on November 15, 2018, issued a final Office Action refusing registration for the “Spark” mark under 15 U.S.C. §1052(d) based on a likelihood of confusion with Plaintiff’s trademark of “Spark Orthodontics.” Id. at ¶19. In early January 2019, Plaintiff became aware that Ormco had just initiated commercialization of products under the “Spark” mark. On January 24, 2019, Plaintiff sent a “cease-and-desist letter” to Ormco, “expressing concern that the use of

1 On April 19, 2021, Spark Orthodontics, PLLC, f/k/a Spark Orthodontics, P.C. assigned the entire interest and goodwill of the trademark to Spark DSO, LLC. Defendant’s Mark with Defendant’s Goods may create a likelihood of confusion.” Id. at ¶ 20; [ECF 10-4, Ex. 6]. At the current time, Ormco is advertising the “Spark Clear Aligner System” nationwide. The Amended Complaint alleges that on January 31, 2019, Ormco contacted the

USPTO examining attorney, after which Ormco’s Application was approved without explanation. Id. at ¶ 21. On February 6, 2019, Ormco responded to Plaintiff’s cease-and-desist letter by citing the fact that the USPTO had recently allowed Ormco’s Application despite its previous two denials. Id. at ¶ 22. On March 26, 2019, the Application for Ormco’s Mark was published for opposition in the Official Gazette. Id. at ¶ 23. On April 17, 2019, Plaintiff timely filed a request for a 90-day extension of time to oppose. Id. at ¶ 24. That request was granted. Id. The Amended Complaint alleges that on May 2, 2019 and May 10, 2019,

Plaintiff’s counsel attempted to resolve the issue of likelihood of confusion with Ormco’s counsel. Id. at ¶ 31. On July 22, 2019, Plaintiff filed a notice of opposition to the Application for Ormco’s “Spark” mark with the USPTO’s Trademark Trial and Appeal Board (“TTAB”) in an attempt to cancel Ormco’s “Spark” mark. Id. at ¶ 25;[ECF 10-4, Ex. 5].2 Plaintiff did not file its original complaint in this action until June 25, 2021.

2 The TTAB proceeding has been stayed at Plaintiff’s request, pending the outcome of this action. Plaintiff alleges that in contradiction to its representations it made to the USPTO, Ormco continues to aggressively target consumers such as patients with its advertising. Id. at ¶ 34. The Amended Complaint further alleges that “Defendant’s conduct is likely to

cause and, upon information and belief, has caused customers to believe mistakenly that infringing products are either affiliated with, endorsed by, authorized by, or somehow connected to Plaintiff and circumvent Plaintiff’s registered Trademark.” Id. at ¶ 38. Finally, the Amended Complaint alleges that “Defendant's acts are causing, and unless restrained, will continue to cause damage and immediate irreparable harm to Plaintiff and to its valuable reputation and goodwill with the consuming public for which Plaintiff has no adequate remedy at law.” Id. at ¶ 39. PRELIMINARY INJUNCTION STANDARD A “[p]reliminary injuncti[on] ... is an ‘extraordinary remedy, which should be

granted only in limited circumstances.’” Ferring Pharms., Inc. v. Watson Pharms., Inc., 765 F.3d 205, 210 (3d Cir. 2014) (quoting Novartis Consumer Health, Inc. v. Johnson & Johnson-Merck Consumer Pharms. Co., 290 F.3d 578, 586 (3d Cir. 2002)). Plaintiff bears the burden of establishing it is “likely to succeed on the merits ...[,] likely to suffer irreparable harm in the absence of preliminary relief, that the balance of equities tips in [its] favor, and that an injunction is in the public interest.” Winter v. NRDC, Inc., 555 U.S. 7, 20 (2008) (citations omitted). The first two factors are “gateway factors” and are “most critical.” Reilly v. City of Harrisburg, 858 F.3d 173, 179 (3d Cir. 2017), as amended (June 26, 2017). If these gateway factors are met, a court then considers the remaining two factors. Id. “A plaintiff's failure to establish any element in [its] favor renders a preliminary injunction inappropriate.” Nutrasweet Co. v. VitMar Enters., 176 F.3d 151, 153 (3d Cir. 1999). With regard to injunctions in trademark cases, the Trademark Modernization Act

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Beacon Theatres, Inc. v. Westover
359 U.S. 500 (Supreme Court, 1959)
Hohe v. Casey
868 F.2d 69 (Third Circuit, 1989)
Frank E. Acierno v. New Castle County
40 F.3d 645 (Third Circuit, 1994)
Tillery v. Leonard & Sciolla, LLP
437 F. Supp. 2d 312 (E.D. Pennsylvania, 2006)
Colleen Reilly v. City of Harrisburg
858 F.3d 173 (Third Circuit, 2017)
David Beasley v. William Howard
14 F.4th 226 (Third Circuit, 2021)
Pallante v. Those Certain Underwriters at Lloyd's
311 F. Supp. 3d 692 (E.D. Pennsylvania, 2018)
Instant Air Freight Co. v. C.F. Air Freight, Inc.
882 F.2d 797 (Third Circuit, 1989)

Cite This Page — Counsel Stack

Bluebook (online)
SPARK ORTHODONTICS v. ORMCO CORPORATION, Counsel Stack Legal Research, https://law.counselstack.com/opinion/spark-orthodontics-v-ormco-corporation-paed-2022.